https://palatin.com/resource/bremelanotide-provides-meaningful-treatment-benefits-for-premenopausal-women-with-hypoactive-sexual-desire-disorder/ 2021-04-27T17:50:47+00:00 https://palatin.com/resource/bremelanotide-for-hypoactive-sexual-desire-disorder-analyses-from-a-phase-2b-dose‐ranging-study/ 2021-04-27T17:50:48+00:00 https://palatin.com/resource/reliability-and-validity-of-the-female-sexual-distress-scale-desire-arousal-orgasm-instrument-in-a-phase-2b-dose-ranging-study-of-bremelanotide/ 2021-04-27T17:50:48+00:00 https://palatin.com/resource/bremelanotide-a-review-of-its-neurobiology-and-treatment-efficacy-for-hsdd/ 2021-04-27T17:50:48+00:00 https://palatin.com/resource/the-neurobiology-and-efficacy-of-bremelanotide-in-hsdd/ 2021-04-27T17:50:48+00:00 https://palatin.com/resource/development-of-a-patient-centric-exit-study-to-contextualize-and-assess-meaningfulness-of-a-potential-treatment-for-hypoactive-sexual-desire-disorder-hsdd/ 2021-04-27T17:50:48+00:00 https://palatin.com/resource/a-placebo-controlled-randomized-double-blind-three-period-three-way-crossover-study-on-the-hemodynamic-and-pharmacokinetic-interactions-of-bremelanotide-and-ethanol/ 2021-04-27T17:52:37+00:00 https://palatin.com/resource/probing-the-role-of-the-mc1-receptor-in-resolution-with-a-selective-mc1-receptor-agonist-pl-8177/ 2021-04-27T17:54:13+00:00 https://palatin.com/resource/probing-the-role-of-the-mc1-receptor-agonists-in-diverse-immunological-diseases/ 2021-04-27T17:54:13+00:00 https://palatin.com/resource/phase-1-study-of-the-novel-a-type-natriuretic-receptor-agonist-pl-3994-in-healthy-volunteers/ 2021-04-27T17:54:54+00:00 https://palatin.com/resource/phase-iia-study-of-the-npr-agonist-pl-3994-in-healthy-adult-volunteers-with-controlled-hypertension/ 2021-04-27T17:54:54+00:00 https://palatin.com/resource/conditional-cardiomyocyte-restricted-corinko-mice-demonstrate-increased-cardiac-hypertrophy-and-pro-fibrotic-gene-activation-in-response-to-tac-and-pl-3994-a-novel-selective-gc-a-receptor-peptide-agon/ 2021-04-27T17:54:54+00:00 https://palatin.com/resource/bremelanotide-an-overview-of-preclinical-cns-effects-on-female-sexual-function/ 2021-04-27T18:04:04+00:00 https://palatin.com/resource/clinical-application-of-cns-acting-agents-in-fsd/ 2021-04-27T18:04:23+00:00 https://palatin.com/resource/melanocortins-in-the-treatment-of-male-and-female-sexual-dysfunction/ 2021-04-27T18:04:42+00:00 https://palatin.com/resource/an-effect-on-the-subjective-sexual-response-in-premenopausal-women-with-sexual-arousal-disorder-by-bremelanotide-pt-141-a-melanocortin-receptor-agonist/ 2021-04-27T18:04:59+00:00 https://palatin.com/resource/selective-facilitation-of-sexual-solicitation-in-the-female-rat-by-a-melanocortin-receptor-agonist/ 2021-04-27T18:05:19+00:00 https://palatin.com/resource/in-vitro-and-in-vivo-pharmacological-profile-of-pl-3994-a-novel-cyclic-peptide-hept-cyclocys-his-phe-d-ala-gly-arg-d-nle-asp-arg-ile-ser-cys-tyr-arg-mimetic-nh2-natriuretic-peptide-receptor-a/ 2021-04-27T18:06:59+00:00 https://palatin.com/resource/treatment-satisfaction-with-subcutaneous-bremelanotide-self-administered-at-home-by-premenopausal-women-with-female-sexual-dysfunction-a-placebo-controlled-dose-ranging-study/ 2021-04-27T18:21:30+00:00 https://palatin.com/resource/efficacy-and-safety-of-the-melanocortin-agonist-pl9643-in-a-phase-2-study-of-subjects-with-dry-eye-disease/ 2021-05-07T23:27:49+00:00 https://palatin.com/resource/protective-effects-of-2-melanocortin-agonists-delivered-by-intravitreal-injection-in-mouse-models-of-retinopathy/ 2021-05-07T23:31:46+00:00 https://palatin.com/resource/investors-day-presentation/ 2021-05-25T14:01:12+00:00 https://palatin.com/resource/h-c-wainwright-global-life-sciences-virtual-conference/ 2021-05-27T15:52:39+00:00 https://palatin.com/resource/the-role-of-the-melanocortin-agonists-in-ocular-indications/ 2021-05-27T15:53:18+00:00 https://palatin.com/resource/efficacy-and-safety-of-the-melanocortin-agonist-pl9643-in-a-phase-2-study-of-subjects-with-dry-eye-disease-2/ 2021-07-07T16:27:25+00:00 https://palatin.com/resource/protective-effects-of-two-melanocortin-agonists-delivered-by-intravitreal-injection-in-mouse-models-of-retinopathy/ 2021-09-16T18:53:21+00:00 https://palatin.com/resource/probing-the-role-of-the-melanocortin-receptor-agonists-in-experimental-immune-mediated-diseases/ 2021-09-17T21:53:31+00:00 https://palatin.com/resource/effect-of-the-melanocortin-receptor-agonist-pl8177-on-dss-induced-colitis-in-rats-and-a-toxicologic-assessment-of-pl8177-in-beagle-dogs/ 2021-09-17T21:53:57+00:00 https://palatin.com/resource/the-melanocortin-pathway-a-new-target-for-ocular-disease-therapy/ 2021-10-01T17:53:18+00:00 https://palatin.com/resource/bremelanotide-is-safe-and-well-tolerated-in-premenopausal-women-with-hypoactive-sexual-desire-disorder-hsdd-safety-results-from-the-reconnect-studies/ 2021-10-13T21:09:04+00:00 https://palatin.com/resource/safety-and-efficacy-of-bremelanotide-for-hsdd-in-women-reconnect-study-open-label-extension-phase-results/ 2021-10-13T21:09:51+00:00 https://palatin.com/resource/changes-in-sexual-functioning-in-the-bremelanotide-reconnect-study/ 2021-10-13T21:13:48+00:00 https://palatin.com/resource/efficacy-of-the-investigational-drug-bremelanotide-in-the-reconnect-studies/ 2021-10-13T21:14:39+00:00 https://palatin.com/resource/bremelanotide-for-hypoactive-sexual-desire-disorder-age-and-weight-subgroup-efficacy-analyses-from-the-reconnect-studies/ 2021-10-13T21:15:48+00:00 https://palatin.com/resource/exit-survey-of-women-with-hypoactive-sexual-desire-disorder-treated-with-bremelanotide-in-the-reconnect-studies-demonstrated-meaningful-treatment-benefits/ 2021-10-13T21:16:18+00:00 https://palatin.com/resource/efficacy-of-bremelanotide-among-women-completing-the-core-phase-of-the-reconnect-studies/ 2021-10-13T21:17:37+00:00 https://palatin.com/resource/reliability-and-validity-of-the-elements-of-desire-questionnaire-in-the-bremelanotide-reconnect-study/ 2021-10-13T21:18:08+00:00 https://palatin.com/resource/conversations-with-women-about-female-sexual-dysfunction-fsd-and-treatment-with-bremelanotide-2/ 2021-10-13T21:19:53+00:00 https://palatin.com/resource/bremelanotide-for-female-sexual-dysfunctions-in-premenopausal-women-a-randomized-placebo-controlled-dose-ranging-trial/ 2021-10-13T21:20:15+00:00 https://palatin.com/resource/drugs-in-early-clinical-development-for-the-treatment-of-female-sexual-dysfunction/ 2021-10-13T21:21:02+00:00 https://palatin.com/resource/melanocortin-receptor-agonists-in-the-treatment-of-male-and-female-sexual-dysfunctions-results-from-basic-research-and-clinical-studies/ 2021-10-13T21:21:30+00:00 https://palatin.com/resource/effect-of-self‐administered-bremelanotide-on-sexual-interest-and-desire-in-premenopausal-women-with-female-sexual-dysfunctions/ 2021-10-13T21:22:01+00:00 https://palatin.com/resource/distress-reduction-in-female-sexual-dysfunctions-a-dose‐ranging-study-of-subcutaneous-bremelanotide/ 2021-10-13T21:22:29+00:00 https://palatin.com/resource/bremelanotide-for-female-sexual-dysfunctions-responder-analyses-from-a-phase-2b-dose-ranging-study/ 2021-10-13T21:23:04+00:00 https://palatin.com/resource/subcutaneous-bremelanotide-for-female-sexual-dysfunctions-in-premenopausal-women-a-responder-analysis/ 2021-10-13T21:23:46+00:00 https://palatin.com/resource/episodic-efficacy-with-subcutaneous-bremelanotide-self-administered-at-home-by-premenopausal-women-with-female-sexual-dysfunction-as-measured-by-the-female-sexual-encounter-profile-revised/ 2021-10-13T21:24:09+00:00 https://palatin.com/resource/efficacy-of-subcutaneous-bremelanotide-self-administered-at-home-by-premenopausal-women-with-female-sexual-dysfunction-a-placebo-controlled-dose-ranging-study/ 2021-10-13T21:24:38+00:00 https://palatin.com/resource/ded-treatments-on-the-horizontolerability-and-efficacy-of-the-melanocortin-agonist-pl9643/ 2022-01-19T16:44:01+00:00 https://palatin.com/resource/cellular-and-molecular-impact-of-the-melanocortin-receptor-agonist-pl8177-in-dextran-sulfate-sodium-dss-induced-colitis-in-rats/ 2022-01-20T18:54:52+00:00 https://palatin.com/resource/kol-webinar-on-dry-eye-disease/ 2022-03-11T17:47:28+00:00 https://palatin.com/resource/effect-of-bremelanotide-on-body-weight-of-obese-women-data-from-two-phase-1-randomized-controlled-trials/ 2022-03-22T18:31:22+00:00 https://palatin.com/resource/eyecelerator-at-ascrs/ 2022-04-21T14:05:27+00:00 https://palatin.com/resource/efficacy-and-impact-of-the-melanocortin-receptor-agonists-pl8177-and-pl9654-in-an-stz-rat-model-of-diabetic-retinopathy/ 2022-05-04T15:31:43+00:00 https://palatin.com/resource/melanocortin-agonist-pl9643-significantly-improves-ocular-signs-and-symptoms-of-moderate-to-severe-dry-eye-disease-including-tear-film-break-up-time/ 2022-05-04T15:33:30+00:00 https://palatin.com/resource/melanocortin-4-receptor-agonism-enhances-sexual-brain-processing-in-women-with-hypoactive-sexual-desire-disorder/ 2023-01-10T14:27:34+00:00 https://palatin.com/resource/melanocortin-4-receptor-agonism-enhances-sexual-brain-processing-in-women-with-hypoactive-sexual-desire-disorder-2/ 2023-01-31T16:10:12+00:00 https://palatin.com/resource/melanocortin-receptor-agonist-pl9588-reduces-intraocular-pressure-in-normotensive-rabbits/ 2023-04-25T12:24:55+00:00 https://palatin.com/resource/effectiveness-of-pl9643-in-treating-the-signs-and-symptoms-of-moderate-to-severe-dry-eye-disease-results-from-2-independent-clinical-trials/ 2023-04-26T14:52:53+00:00 https://palatin.com/resource/efficacy-of-the-melanocortin-receptor-agonist-pl8177-as-a-potential-therapy-for-gastrointestinal-inflammatory-diseases/ 2023-05-09T12:30:18+00:00 https://palatin.com/resource/melanocortin-1-receptor-mc1r-agonist-pl8177-protects-against-podocyte-loss-in-a-streptozotocin-induced-rat-model-of-diabetic-nephropathy/ 2023-05-26T09:41:01+00:00 https://palatin.com/resource/cellular-and-molecular-impact-of-the-melanocortin-receptor-agonist-pl8177-in-dextran-sulfate-sodium-induced-colitis-in-rats/ 2023-10-16T08:28:22+00:00 https://palatin.com/resource/melanocortin-receptor-4-agonist-pl8905-in-combination-with-glucagon-like-peptide-1-produces-synergistic-weight-loss-reduced-food-intake-and-greater-glucose-control-in-diet-induced-obese-rats/ 2023-10-19T11:09:37+00:00 https://palatin.com/resource/efficacy-of-the-melanocortin-receptor-agonist-pl8177-as-a-potential-therapy-for-gastrointestinal-inflammatory-diseases-2/ 2023-11-02T15:49:18+00:00 https://palatin.com/resource/cellular-and-molecular-impact-of-the-melanocortin-receptor-agonist-pl8177-in-dextran-sulfate-sodium-induced-colitis-in-rats-2/ 2023-11-02T15:49:30+00:00 https://palatin.com/resource/a-new-approach-for-the-treatment-of-ulcerative-colitis-a-melanocortin-receptor-agonist-pl8177/ 2024-01-30T07:35:58+00:00 https://palatin.com/resource/virtual-kol-event-beyond-glps-the-multiple-roles-for-novel-melanocortin-receptor-4-agonists-in-treating-obesity-and-weight-loss-maintenance/ 2024-05-08T16:41:37+00:00 https://palatin.com/resource/structural-modifications-allow-the-removal-of-melanocortin-receptor-1-agonism-from-melanocortin-receptor-4-agonists/ 2024-10-22T16:20:52+00:00 https://palatin.com/resource/harnessing-the-melanocortin-system-to-heal-inflammatory-diseases/ 2024-10-23T13:30:08+00:00 https://palatin.com/resource/melanocortin-agonist-pl7737-causes-weight-loss-and-decreases-food-consumption-in-obese-mice/ 2024-11-04T07:30:52+00:00 https://palatin.com/resource/efficacy-of-bremelanotide-bmt-to-stabilize-podocyte-function-and-reduce-proteinuria-in-adults-with-type-ii-diabetic-nephropathy-results-from-a-phase-iib-open-label-study/ 2025-04-08T08:17:31+00:00 https://palatin.com/resource/activating-the-melanocortin-system-resolves-inflammation-reduces-vegf-signaling-in-diabetic-retinopathy-dr-and-provides-retinal-ganglion-cell-rgc-protection/ 2025-05-09T09:49:23+00:00 https://palatin.com/resource/efficacy-and-safety-of-pl9643-in-dry-eye-disease-results-from-a-phase-3-randomized-vehicle-controlled-study/ 2025-05-09T09:49:28+00:00 https://palatin.com/resource/activation-of-the-melanocortin-system-increases-aqueous-outflow-reduces-intraocular-pressure-iop-and-protects-neurons-in-glaucoma-models/ 2025-05-09T09:49:32+00:00 https://palatin.com/resource/co-administration-of-bremelanotide-with-tirzepatide-in-participants-with-obesity/ 2025-11-06T14:59:26+00:00 https://palatin.com/resource/characterization-of-the-melanocortin-receptor-4-oral-small-molecule-agonist-pl7737/ 2025-11-06T14:59:29+00:00